Sanofi: sellers take back control
Sanofi stock drops 2.1% as sellers retake control of the week
Sanofi: sellers take back control
Our view last week
Sanofi shares stay boxed in a very tight corridor, right at the edge of the Inversion Point in the 77.8 area: this week the stock slipped 1.7% and sellers took back control of volume, reversing the pattern of the previous three weeks. Momentum, negative for a month, turned positive for the first time, while the MACD closes in on a bullish cross. The short, open for 11 weeks, stays just over 4% underwater, with earnings due July 30 keeping attention high.
This week's summary
Sanofi shares slipped 2.1% this week as sellers retook control of volume, 70% to 30%, after the previous rebound. The MACD, which had brushed a bullish cross, stalled, and money flow stays positive but fading. The short, under management for 13 weeks, trims its loss to just under 2%: Sanofi stock technical analysis, with earnings now behind it.
IQS Phase
70
in tension
Signal Strength
40
downtrend making lower lows, pace holding
Sizing
REDUCED
Ranking
#12 / 47
EU-UK stocks
Trade P&L %
-1.87%
from signal to date, no stop loss
Rank position
ranks 12th among the 47 sell signals for European-UK stocks in our ranking, with a signal strength of 40 out of 100.
Sector context
SectorEuropean
Benchmark ETFEXV4
Sector regimein positive regime
Performanceweekly -0.61% · monthly -2.43%
SAN belongs to the european sector (reference ETF EXV4). The sector is classified in positive regime according to our weekly reading.
restricted Platinum content